Pharmaceutical companies around the world have agreed to make results from clinical trials of new prescription medicines publicly available, it was announced last week.

The voluntary agreement has been drawn up by the world's main pharmaceutical industry trade associations and agreed by key companies. It states that summary results of completed, industry sponsored clinical trials will be publicly disclosed on free and publicly accessible databases, regardless of outcome, for any medicine approved …